XENON PHARMACEUTICALS INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $541.9M | $116.5M |
| Jun 2022 | — | $785.8M | $370.0M |
| Sep 2022 | — | $753.1M | $103.5M |
| Dec 2022 | — | $721.5M | $57.2M |
| Mar 2023 | — | $686.9M | $69.5M |
| Jun 2023 | — | $646.5M | $64.6M |
| Sep 2023 | — | $636.6M | $99.6M |
| Dec 2023 | — | $927.9M | $148.6M |
| Mar 2024 | — | $887.7M | $58.9M |
| Jun 2024 | — | $844.0M | $136.7M |
| Sep 2024 | — | $797.8M | $87.6M |
| Dec 2024 | — | $754.9M | $142.7M |
| Mar 2025 | — | $704.0M | $116.7M |
| Jun 2025 | — | $634.0M | $135.4M |
| Sep 2025 | — | $559.5M | $104.5M |
| Dec 2025 | — | $581.8M | $199.2M |
| Mar 2026 | — | $1.34B | $545.9M |
| Jun 2026 | — | $1.24B | $119.5M |